Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table

Ramsay et al estimate that 4.8% of the UK population aged 35-69 years may be candidates for secondary prevention of coronary heart disease (CHD) by statin treatment. This treatment might reasonably be targeted at a CHD event risk of 3% per year.

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) 1996-08, Vol.348 (9024), p.387-388
Main Authors:	Ramsay, LE, Haq, IU, Jackson, PR, Yeo, WW, Pickin, DM, Payne, JN
Format:	Article
Language:	eng
Subjects:	Adult Aged Biological and medical sciences Cardiovascular disease Coronary Disease - prevention & control Drug therapy Female General and cellular metabolism. Vitamins Health risk assessment Humans Hypolipidemic Agents - therapeutic use Male Medical sciences Middle Aged Pharmacology. Drug treatments Prevention Primary Prevention - methods Risk
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Ramsay et al estimate that 4.8% of the UK population aged 35-69 years may be candidates for secondary prevention of coronary heart disease (CHD) by statin treatment. This treatment might reasonably be targeted at a CHD event risk of 3% per year.
ISSN:	0140-6736 1474-547X